To assess the performance of plasma neurofilament light (NfL) and phosphorylated tau 181 (p-tau181) to inform about cerebral Alzheimer’s disease (AD) pathology and predict clinical progression in a memory clinic setting. The gene discussed is NEFL; the disease is early-onset autosomal dominant Alzheimer disease.